- EUR/USD:1.1851+0.0013+0.11%
- Natural Gas:4.1350-0.0280-0.67%
- UK 100:7,122.65+1.8500+0.03%
- GBP/JPY:152.55+0.3370+0.22%
- WTI Oil:68.445+0.2860+0.42%
- USD/JPY:109.50-0.0205-0.02%
- S&P 500:4,402.66-20.490-0.46%
- AUD/USD:0.7411+0.0031+0.43%
- Silver:25.471+0.0843+0.33%
- USD/CAD:1.2504-0.0044-0.35%
- Corn:5.9745+0.0165+0.28%
- EUR/USD:1.1851+0.0013+0.11%
- Natural Gas:4.1350-0.0280-0.67%
- UK 100:7,122.65+1.8500+0.03%
- GBP/JPY:152.55+0.3370+0.22%
- WTI Oil:68.445+0.2860+0.42%
- USD/JPY:109.50-0.0205-0.02%
- S&P 500:4,402.66-20.490-0.46%
- AUD/USD:0.7411+0.0031+0.43%
- Silver:25.471+0.0843+0.33%
- USD/CAD:1.2504-0.0044-0.35%
- Corn:5.9745+0.0165+0.28%
Opinions
- Bob MasonBrexit Update – Talks Continue as EU Member States Keep an Eye on Barnier
Time is running out and yet both sides stand firm on the remaining hurdles. The markets and the Pound continue to reflect optimism, however.
- Bob MasonCOVID-19 Vaccine Update – Moderna Inc. Requests Approval from the FDA and the EMA
Moderna Inc. submits its EUA to the FDA, with both Pfizer Inc. and Moderna Inc. also submitting requests to the EMA.
- Bob MasonCOVID-19 Vaccine Update – Focus Shifts to Pre-orders and Distribution
AstraZeneca last week announced plans to launch a new global trial. Without the AstraZeneca vaccine, however, many nations will be without…
- Vladimir ZernovStocks Look Ready To Test New Highs Amid Vaccine Optimism And Stimulus Hopes
There is some rotation from tech stocks into cyclical stocks.
- Bob MasonCOVID-19 Vaccine Update – AstraZeneca Leaves the Door Ajar for Other Pharmas
As more details emerge from AstraZeneca’s clinical trials, the door may be ajar for another U.S pharma to make a move.
- Bob MasonBrexit – A New President Who Just Doesn’t Think Like Donald
As Brexit talks get set to resume, Boris may be feeling hot under the collar. A message from Biden and a warning from the EU. Compromise or else…
- Bob MasonBrexit – Mixed Signals and Anger on the British Side of the Channel
Face to face talks are set to resume with Barnier coming out of self-isolation. The two sides at odds, however, with time running out.
- Bob MasonCOVID-19 Vaccine Update – AstraZeneca Releases Trial Results
AstraZeneca and the University of Oxford fail to impress the markets with phase 3 trial results. Logistics and production could favor their vaccine, however.
- Bob MasonCOVID-19 Vaccine Update – Pfizer Inc. Submits an EUA
Pfizer Inc. and BioNTech submit a EUA. Moderna Inc. and AstraZeneca need to catch up…
- Bob MasonBrexit – Talks Hit Pause, with Calls for an Extension Beginning to Surface
Brexit talks hit pause as EU negotiators self-isolate. With the transition period ending in just over a month, is an extension around the corner?
- Bob MasonCOVID-19 Vaccine Update – The Numbers are Impressive but the Markets Need More
Pfizer Inc. addresses safety concerns and virus efficacy amongst the elderly. Is it enough for the FDA to approve and for manufacturing to commence?
- Bob MasonBrexit – Politics is a Game and Neither Side Wants to Concede
The proverbial can continues to get kicked down the road. Brexit talks continue and the EU Summit on Thursday may not be the end of it.
- Bob MasonCOVID-19 – Moderna Delivers Even More Impressive Results
Moderna Inc. delivers the world with yet more hope of an end to the global pandemic. More data is going to be needed, however.
- Bob MasonCOVID-19 – Updates on Vaccine Trials are coming. Is Pfizer Still out Ahead?
More clinical trial results are due out from Pharmas in the coming weeks. Safety, duration, and manufacturing data from Pfizer will also be in focus.
- Bob MasonWhite House Down – Trump’s Ultimate Mission?
Anarchy or an orderly handover? There are reasons why the markets should worry…
- Bob MasonBrexit – Another Deadline Gives Negotiators 7-Days to Wrap Up a Deal
It’s the final countdown. EU – UK negotiators have until the 19th November EU Summit to wrap things up.
- Bob MasonCOVID-19 – Pfizer Leads the Race to a COVID-19 Vaccine
Pfizer Inc. and BioNTech SE deliver positive news on Monday. There is a long way to go before a worldwide vaccine, however.
- Bob MasonCOVID-19 – The Race to a Vaccine
The pharmaceutical sector is in a race to deliver an effective COVID-19 vaccine as the 2nd wave hits the West. A number of pharmas lead the way.
- Bob MasonBrexit and U.S Politics – It Could Go Horribly Wrong for Boris and the Brexiteers
Boris Johnson may rue allowing talks to extend beyond October. A Biden victory will put the cat amongst the pigeons…
- Bob MasonCOVID-19 Hits Europe and the U.S Once More. How Will Asian Governments Respond?
The 2nd wave of the COVID-19 pandemic could have a far more severe economic impact. Can Asia avoid the meltdown?
